Miniatura

Fitxers

Gomez-AceboI.pdf (932.44 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2020-06-01

Llicència de publicació

cc by (c) Gómez Acebo et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173025

Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1007/s10549-020-05600-x

Resum

Purpose: The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. Method: The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Results: Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Conclusion: Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased.

Matèries

Càncer de mama, Epidemiologia

Matèries (anglès)

Breast cancer, Epidemiology

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (ISGlobal)

Citació

GÓMEZ ACEBO, Inés, DIERSSEN SOTOS, Trinidad, PALAZUELOS-CALDERÓN, Camilo, PÉREZ GÓMEZ, Beatriz, AMIANO, Pilar, GUEVARA, Marcela, MOLINA DE LA TORRE, Antonio josé, DOMINGO, Laia, FERNÁNDEZ ORTIZ, María, MORENO AGUADO, Víctor, ALGUACIL, Juan, FERNÁNDEZ TARDÓN, Guillermo, IBÁÑEZ, Josefa, MARCOS GRAGERA, Rafael, DIAZ SANTOS, Marian, ALONSO AGUADO, Maria henar, ALONSO MOLERO, Jéssica, CASTAÑO-VINYALS, Gemma, GARCÍA PALOMO, Andrés, ARDANAZ, Eva, MOLINUEVO, Amaia, ARAGONÈS SANZ, Núria, KOGEVINAS, Manolis, POLLÁN, Marina, LLORCA, Javier. Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study. _Breast Cancer Research and Treatment_. 2020. Vol. 181, núm. 3, pàgs. 667-678. [consulta: 24 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/173025]

Exportar metadades

JSON - METS

Compartir registre